{
  "docId": "019dd923-622c-750b-8b9a-101b5bfde4b8",
  "docSlug": "a70fecd99534",
  "documentTitle": "Berkeley Lights (BLI)",
  "authorId": "58_Scorpion_Capital",
  "authorName": "Scorpion Capital",
  "documentKindSlug": "research-note",
  "documentKindLabel": "Research note",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2021-09-15 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.2941177,
  "pageNumber": 98,
  "pageCount": 158,
  "prevPage": 97,
  "nextPage": 99,
  "slideType": "testimonial",
  "function": "expose_contradiction",
  "density": "overcrowded",
  "nDataPoints": 3,
  "notes": "The slide uses a Q&A format to highlight specific failures of the product.",
  "elementsJson": [
    "headline_text",
    "paragraph",
    "quote_block",
    "footnote"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b9a-101b5bfde4b8/98",
  "deckHref": "/decks/019dd923-622c-750b-8b9a-101b5bfde4b8",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b9a-101b5bfde4b8.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b9a-101b5bfde4b8#slide-98",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "Former executive closely involved with purchase and use says they would have sent it back for a refund if they could; lack of ROI; only worked 50% of the time; failed on many levels - high operating cost, data/output issues, lack of support.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-2042-70a9-a1ac-17024d041f0d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.9,
        "x": 0.05,
        "y": 0.08
      },
      "kind": "paragraph",
      "text": "HARBOUR BIOMED, based in Asia and focused on antibody development for oncology and immunology. Former executive closely involved with purchase and use says they would have sent it back for a refund if they could; lack of ROI; only worked 50% of the time; failed on many levels - high operating cost, data/output issues, lack of support.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7f616dd9-4ba5-4e5f-80dd-eea16a50c98b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.9,
        "x": 0.05,
        "y": 0.65
      },
      "kind": "quote",
      "text": "Machine only worked about 50% of the time; cost per run is too restrictive to keep troubleshooting it. \"In terms of expectations against reality, I would say it's somewhere around the 50% hit or miss rate.\"",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2b73601d-c8f4-4c57-8fe3-700eecc993ee",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.9,
        "x": 0.05,
        "y": 0.25
      },
      "kind": "quote",
      "text": "Expert was an executive involved in the decision to purchase BLI machine, for antibody discovery in immunology and oncology applications. \"I was involved in the decision to buy it, in 2019... The idea was to speed things up in terms of antibody discovery, with Beacon.\"",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "304017ad-87ff-4f5c-bae6-81d1031705f4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.9,
        "x": 0.05,
        "y": 0.82
      },
      "kind": "quote",
      "text": "BLI failed on multiple dimensions: too expensive to operate; lack of data/output; lack of support. \"But given that each run ran $15,000 to $17,000... not being able to get the level of data and output that you're expecting...\"",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3e43724f-bcb2-412f-873c-8be6faa77cbe",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.9,
        "x": 0.05,
        "y": 0.45
      },
      "kind": "quote",
      "text": "Harbour would have sent the machine back if they could; lack of ROI. Q: \"It sounds like, you would have returned it in a heartbeat?\" A: \"Yes, because again, as I said, the cost of operating it... was just not a good return on investment.\"",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a7dab860-0825-48ff-8828-d8aafacc1d2c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "“I was involved in the decision to buy it, in 2019... The idea was to speed things up in terms of antibody discovery, with Beacon.” — Harbour Biomed ex-executive; “Yes, because again, as I said, the cost of operating it, the amount of time that we were spending troubleshooting and learning, and finally, at the end of the day, the amount of benefit that we were receiving was just not a good return on investment.” — Harbour Biomed ex-executive; “In terms of expectations against reality, I would say it's somewhere around the 50% hit or miss rate.” — Harbour Biomed ex-executive; “But given that each run ran $15,000 to $17,000, we were apprehensive about spending that kind of money on it. But from the get-go, to go in with that kind of pricing, not being able to get the level of data and output that you're expecting, I think that probably didn't work out in the right way, and the marketing tactics and the support that they decided to have.” — Harbour Biomed ex-executive",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd953-2042-70a9-a1ac-183f9a96acf4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.25,
        "x": 0.05,
        "y": 0.96
      },
      "kind": "source-note",
      "text": "Source: Scorpion Capital consultation calls with experts",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f2bb6447-9518-4d54-bec1-37e1d6be0502",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.3,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "2K) Harbour Biomed ex-executive",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "faf077ea-2696-4455-b8b4-9a27a9e3cd2f",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 150,
      "from": 42,
      "beatId": "172d6e2f-be3f-4802-92e5-e7e412ccdabe",
      "arcName": "Overcoming the Monster",
      "arcSlug": "overcoming-monster",
      "beatName": "Testimonials from Customers and Former Employees",
      "beatSlug": null,
      "evidence": "The document presents testimonials from customers and former employees, providing first-hand accounts of the challenges and limitations of Berkeley Lights' product.",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}